About The Mighty

Backed by Digitalis, GGV, and Upfront Ventures, The Mighty has built a healthcare community with 3.3mm members across 1,500 conditions, their AI engine collects anonymized data points from over 18mm conversations and connections to deliver actionable insights into symptoms, treatments, dosages, diagnosis, and more for their healthcare clients.

Revenue has grown 65% YoY to $7.1mm in 2021 serving top pharma companies including Pfizer, AbbVie, Roche, AstraZeneca, Merck, AmGen, J&J, and Bristol Myers Squibb.

$5mm is available in a convertible note to Series C, led by Digitalis